Cargando…

Cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration

The adult central nervous system (CNS) possesses a limited capacity for self-repair. Severed CNS axons typically fail to regrow. There is an unmet need for treatments designed to enhance neuronal viability, facilitate axon regeneration, and ultimately restore lost neurological functions to individua...

Descripción completa

Detalles Bibliográficos
Autores principales: Jerome, Andrew D., Sas, Andrew R., Wang, Yan, Wen, Jing, Atkinson, Jeffrey R., Webb, Amy, Liu, Tom, Segal, Benjamin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635390/
https://www.ncbi.nlm.nih.gov/pubmed/37961609
http://dx.doi.org/10.21203/rs.3.rs-3491540/v1
_version_ 1785146339329310720
author Jerome, Andrew D.
Sas, Andrew R.
Wang, Yan
Wen, Jing
Atkinson, Jeffrey R.
Webb, Amy
Liu, Tom
Segal, Benjamin M.
author_facet Jerome, Andrew D.
Sas, Andrew R.
Wang, Yan
Wen, Jing
Atkinson, Jeffrey R.
Webb, Amy
Liu, Tom
Segal, Benjamin M.
author_sort Jerome, Andrew D.
collection PubMed
description The adult central nervous system (CNS) possesses a limited capacity for self-repair. Severed CNS axons typically fail to regrow. There is an unmet need for treatments designed to enhance neuronal viability, facilitate axon regeneration, and ultimately restore lost neurological functions to individuals affected by traumatic CNS injury, multiple sclerosis, stroke, and other neurological disorders. Here we demonstrate that both mouse and human bone marrow (BM) neutrophils, when polarized with a combination of recombinant interleukin (IL)-4 and granulocyte-colony stimulating factor (G-CSF), upregulate alternative activation markers and produce an array of growth factors, thereby gaining the capacity to promote neurite outgrowth. Moreover, adoptive transfer of IL-4/G-CSF polarized BM neutrophils into experimental models of CNS injury triggered substantial axon regeneration within the optic nerve and spinal cord. These findings have far-reaching implications for the future development of autologous myeloid cell-based therapies that may bring us closer to effective solutions for reversing CNS damage.
format Online
Article
Text
id pubmed-10635390
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-106353902023-11-13 Cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration Jerome, Andrew D. Sas, Andrew R. Wang, Yan Wen, Jing Atkinson, Jeffrey R. Webb, Amy Liu, Tom Segal, Benjamin M. Res Sq Article The adult central nervous system (CNS) possesses a limited capacity for self-repair. Severed CNS axons typically fail to regrow. There is an unmet need for treatments designed to enhance neuronal viability, facilitate axon regeneration, and ultimately restore lost neurological functions to individuals affected by traumatic CNS injury, multiple sclerosis, stroke, and other neurological disorders. Here we demonstrate that both mouse and human bone marrow (BM) neutrophils, when polarized with a combination of recombinant interleukin (IL)-4 and granulocyte-colony stimulating factor (G-CSF), upregulate alternative activation markers and produce an array of growth factors, thereby gaining the capacity to promote neurite outgrowth. Moreover, adoptive transfer of IL-4/G-CSF polarized BM neutrophils into experimental models of CNS injury triggered substantial axon regeneration within the optic nerve and spinal cord. These findings have far-reaching implications for the future development of autologous myeloid cell-based therapies that may bring us closer to effective solutions for reversing CNS damage. American Journal Experts 2023-10-31 /pmc/articles/PMC10635390/ /pubmed/37961609 http://dx.doi.org/10.21203/rs.3.rs-3491540/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Jerome, Andrew D.
Sas, Andrew R.
Wang, Yan
Wen, Jing
Atkinson, Jeffrey R.
Webb, Amy
Liu, Tom
Segal, Benjamin M.
Cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration
title Cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration
title_full Cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration
title_fullStr Cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration
title_full_unstemmed Cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration
title_short Cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration
title_sort cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635390/
https://www.ncbi.nlm.nih.gov/pubmed/37961609
http://dx.doi.org/10.21203/rs.3.rs-3491540/v1
work_keys_str_mv AT jeromeandrewd cytokinepolarizedalternativelyactivatedbonemarrowneutrophilsdriveaxonregeneration
AT sasandrewr cytokinepolarizedalternativelyactivatedbonemarrowneutrophilsdriveaxonregeneration
AT wangyan cytokinepolarizedalternativelyactivatedbonemarrowneutrophilsdriveaxonregeneration
AT wenjing cytokinepolarizedalternativelyactivatedbonemarrowneutrophilsdriveaxonregeneration
AT atkinsonjeffreyr cytokinepolarizedalternativelyactivatedbonemarrowneutrophilsdriveaxonregeneration
AT webbamy cytokinepolarizedalternativelyactivatedbonemarrowneutrophilsdriveaxonregeneration
AT liutom cytokinepolarizedalternativelyactivatedbonemarrowneutrophilsdriveaxonregeneration
AT segalbenjaminm cytokinepolarizedalternativelyactivatedbonemarrowneutrophilsdriveaxonregeneration